A Unique Opportunity to Unlock Opportunities in Hippo Pathway and Small Molecule Drug Development

As the Hippo industry continues burgeoning with novel drug development, leading Hippo experts are actively seeking your services and solutions to advance their R&D efforts and unleash the potential of the next-generation of Hippo drugs. Leading Hippo experts are actively seeking your services and solutions to advance their R&D efforts and unleash the potential of the next-generation of Hippo drugs.

We collaborate with cutting-edge service providers offering capabilities in small molecule libraries, hit screening, chemoproteomics, computational biology tools, pre-clinical models and assay development for small molecule drug developers. Our goal is to unite the industry, overcome existing challenges, and unlock the potential of Hippo pathway-targeted therapies.

Leverage this global virtual platform to connect with small molecule drug developers across North America, Europe & Asia to demonstrate how your business can empower key decision-makers.